These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17159722)

  • 41. [Digestive manifestations in systemic sclerosis].
    Attar A
    Ann Med Interne (Paris); 2002 Jun; 153(4):260-4. PubMed ID: 12218892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gastrointestinal tract involvement in systemic sclerosis].
    Renaud A; Jirka A; Durant C; Connault J; Espitia O; Takoudju C; Agard C
    Rev Med Interne; 2023 Aug; 44(8):410-422. PubMed ID: 37270380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications requiring operative intervention in scleroderma.
    Netscher DT; Richardson JD
    Surg Gynecol Obstet; 1984 May; 158(5):507-12. PubMed ID: 6369588
    [No Abstract]   [Full Text] [Related]  

  • 44. GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.
    Tétreault MP; Kahrilas P
    Curr Rheumatol Rep; 2019 Jul; 21(8):42. PubMed ID: 31270707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus.
    Hoffmann KM; Gibril F; Entsuah LK; Serrano J; Jensen RT
    J Clin Endocrinol Metab; 2006 Jan; 91(1):204-12. PubMed ID: 16249283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current management of the gastrointestinal complications of systemic sclerosis.
    Emmanuel A
    Nat Rev Gastroenterol Hepatol; 2016 Aug; 13(8):461-72. PubMed ID: 27381075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders.
    Weston S; Thumshirn M; Wiste J; Camilleri M
    Am J Gastroenterol; 1998 Jul; 93(7):1085-9. PubMed ID: 9672335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation and management of gastrointestinal manifestations in scleroderma.
    Kirby DF; Chatterjee S
    Curr Opin Rheumatol; 2014 Nov; 26(6):621-9. PubMed ID: 25207461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.
    Marie I; Levesque H; Ducrotté P; Denis P; Benichou J; Hellot MF; Cailleux N; Le Loët X; Joly P; Lauret P; Courtois H
    Arthritis Rheum; 1998 Oct; 41(10):1874-83. PubMed ID: 9778230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastroesophageal Reflux Disease-Related Disorders of Systemic Sclerosis Based on the Analysis of 66 Patients.
    Matsuda R; Yamamichi N; Shimamoto T; Sumida H; Takahashi Y; Minatsuki C; Kodashima S; Ono S; Niimi K; Tsuji Y; Sakaguchi Y; Saito I; Kataoka Y; Asada-Hirayama I; Kakimoto H; Yakabi S; Takeuchi C; Matsumoto Y; Tamaki Z; Fujishiro M; Asano Y; Sato S; Koike K
    Digestion; 2018; 98(4):201-208. PubMed ID: 30045036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benign strictures of the esophagus.
    Bremner CG
    Curr Probl Surg; 1982 Aug; 19(8):401-89. PubMed ID: 7049590
    [No Abstract]   [Full Text] [Related]  

  • 53. Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis: A Systematic Review.
    Brandler JB; Sweetser S; Khoshbin K; Babameto M; Prokop LJ; Camilleri M
    Am J Gastroenterol; 2019 Dec; 114(12):1847-1856. PubMed ID: 31805016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Esophageal dysfunction in scleroderma: relationship with disease subsets.
    Bassotti G; Battaglia E; Debernardi V; Germani U; Quiriconi F; Dughera L; Buonafede G; Puiatti P; Morelli A; Spinozzi F; Mioli PR; Emanuelli G
    Arthritis Rheum; 1997 Dec; 40(12):2252-9. PubMed ID: 9416865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
    Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
    J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric involvement in systemic sclerosis: a prospective study.
    Marie I; Levesque H; Ducrotté P; Denis P; Hellot MF; Benichou J; Cailleux N; Courtois H
    Am J Gastroenterol; 2001 Jan; 96(1):77-83. PubMed ID: 11197291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
    Christmann RB; Wells AU; Capelozzi VL; Silver RM
    Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal complications of systemic sclerosis.
    Tian XP; Zhang X
    World J Gastroenterol; 2013 Nov; 19(41):7062-8. PubMed ID: 24222949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up.
    Marie I; Ducrotté P; Denis P; Hellot MF; Levesque H
    Rheumatology (Oxford); 2007 Jan; 46(1):150-3. PubMed ID: 16782730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systemic sclerosis with various gastrointestinal problems including pneumoperitoneum, pneumatosis cystoides intestinalis and malabsorption syndrome].
    Satoh A; Hoshina Y; Shimizu H; Morita K; Uchiyama M; Moriuchi J; Takaya M; Ichikawa Y
    Ryumachi; 1995 Dec; 35(6):927-33. PubMed ID: 8720272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.